| RS144164620 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS1441649062 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS144165094 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS1441654871 |
SOX11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism |
| RS1441655600 |
ERCC6
|
Health Risk |
Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, DE SANCTIS-CACCHIONE SYNDROME |
| RS1441655868 |
MED17
|
Health Risk |
Pathogenic |
— |
| RS1441657866 |
ETFDH
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS144165818 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS1441659798 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS144166142 |
TSPEAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TSPEAR-related disorder |
| RS144166844 |
ADAMTS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani syndrome, Inborn genetic diseases |
| RS144167138 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1441671810 |
AR
|
Health Risk |
Likely pathogenic |
Ovarian cancer, Ovarian cancer |
| RS144168709 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS144169027 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hennekam lymphangiectasia-lymphedema syndrome 1, Hennekam lymphangiectasia-lymphedema syndrome 1 |
| RS144169073 |
CHRNE
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4C |
| RS144169411 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Congenital myasthenic syndrome 17 |
| RS144169488 |
PHYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Phytanic acid storage disease |
| RS144170692 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
UNC80-related disorder, Hypotonia |
| RS144171225 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS144172190 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS144172463 |
ATP6V0A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive distal renal tubular acidosis, Autosomal recessive distal renal tubular acidosis |
| RS144172724 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS144172952 |
ASTN2;TRIM32
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 11, Sarcotubular myopathy |
| RS144173352 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS144174126 |
EDC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1441743655 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS144174426 |
DCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stromal corneal dystrophy, Inborn genetic diseases |
| RS1441752228 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1441753402 |
LHX3
|
Health Risk |
Pathogenic |
— |
| RS1441766008 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS144177566 |
ALDH5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Succinate-semialdehyde dehydrogenase deficiency, ALDH5A1-related disorder |
| RS1441779135 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS144178015 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS144178018 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS144178150 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome, Colorectal cancer |
| RS144178755 |
PER3
|
Health Risk |
Conflicting classifications of pathogenicity |
PER3-related disorder, PER3-related disorder |
| RS144179865 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS144180211 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS144180493 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1441817658 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy |
| RS144181834 |
KL
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS144181978 |
DGUOK
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 |
| RS144182297 |
FYCO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 18, FYCO1-related disorder |
| RS1441826695 |
PIEZO1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS144182725 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS144182857 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Autoinflammatory syndrome |
| RS144182921 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS144182966 |
CACNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS144183238 |
PRX
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS1441833591 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS144183694 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1441845742 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS144185168 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 4, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1441862662 |
GJB2
|
Health Risk |
Pathogenic |
— |
| RS144186721 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1441877386 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 14, Nephronophthisis |
| RS144187782 |
ARPC1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, ARPC1B-related disorder |
| RS144187959 |
TECPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia |
| RS144189491 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS144189610 |
AP4E1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS144189837 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS144190333 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, Inborn genetic diseases |
| RS144190399 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS144190443 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Alagille syndrome due to a JAG1 point mutation |
| RS1441909908 |
GBA1
|
Health Risk |
Likely pathogenic |
— |
| RS144191570 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Noonan syndrome and Noonan-related syndrome |
| RS144191823 |
CEP89
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1441922749 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS144192700 |
ABCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dubin-Johnson syndrome, ABCC2-related disorder |
| RS144192844 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS144192900 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1441933780 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS144193508 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1441937053 |
CD46
|
Health Risk |
Pathogenic |
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly, Atypical hemolytic-uremic syndrome |
| RS1441937959 |
EFL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Shwachman-Diamond syndrome 2, Shwachman syndrome |
| RS144195765 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1441983264 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS144199562 |
TTBK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 11, TTBK2-related disorder |
| RS144200345 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hyperinsulinism, Transitory neonatal diabetes mellitus |
| RS144200355 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Gallbladder disease 4 |
| RS144200704 |
BCS1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 1, Leigh syndrome |
| RS144200709 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1442013338 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Infantile liver failure syndrome 2 |
| RS144201778 |
TGM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Spinocerebellar ataxia type 35 |
| RS144203670 |
MCCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 2 deficiency, Methylcrotonyl-CoA carboxylase deficiency |
| RS144203682 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1442037817 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS144204375 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS144204614 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS1442053811 |
IL1RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Sterile multifocal osteomyelitis with periostitis and pustulosis |
| RS1442056564 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Norman-Roberts syndrome |
| RS1442062349 |
ELANE
|
Health Risk |
Likely pathogenic |
Cyclical neutropenia, Neutropenia |
| RS144206255 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, SI-related disorder |
| RS144206271 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Inborn genetic diseases |
| RS1442064385 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS144206837 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS144207158 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Hyperinsulinemic hypoglycemia |
| RS144207207 |
PTPRJ
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1442078154 |
DNAI2
|
Health Risk |
Pathogenic/Likely pathogenic |
DNAI2-related disorder, Primary ciliary dyskinesia 9 |